Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Insignis Therapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Insignis Therapeutics

Insignis Therapeutics

Pre-Seed

Insignis Therapeutics, a Connecticut-based pharmaceutical firm, develops oral epinephrine tablets for emergency anaphylaxis treatment.

HQ
North Haven, CT, US
Founded
2018
Overview
Compare
Fundraising
Employees

Insignis Therapeutics, based in North Haven, Connecticut, is dedicated to developing and commercializing an innovative oral epinephrine tablet for emergency anaphylaxis treatment. The company collaborates with strategic partners to leverage complementary resources, focusing on creating accessible and effective solutions for severe allergic reactions.

Insignis Therapeutics has made significant strides in the pharmaceutical industry by advancing the development of their oral epinephrine formulation. Their work aims to provide a more convenient and potentially life-saving alternative to traditional epinephrine auto-injectors, impacting the lives of individuals at risk of anaphylaxis.

Insignis Therapeutics - Similar Companies

Bryn Pharma logo

Bryn Pharma

brynpharma.com

Insero Health logo

Insero Health

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Exalys Therapeutics logo

Exalys Therapeutics

Belhaven Biopharma logo

Belhaven Biopharma

belhavenbio.com

Optinose logo

Optinose

optinose.com

Sigyn Therapeutics logo

Sigyn Therapeutics

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

Zena Therapeutics logo

Zena Therapeutics

ISI Life Sciences logo

ISI Life Sciences

Epalex logo

Epalex

epalex.com

Courage Therapeutics logo

Courage Therapeutics

Visum Pharma logo

Visum Pharma

visumpharmainc.com

Accuitis logo

Accuitis

accuitis.com

Insignis Therapeutics - Quick Facts

Who are Insignis Therapeutics' competitors?

Companies similar to Insignis Therapeutics include Bryn Pharma, Insero Health, ARS Pharmaceuticals and Concours Pharmaceuticals.

When was Insignis Therapeutics founded?

Insignis Therapeutics was founded in 2018.

Where is Insignis Therapeutics' headquarters located?

Insignis Therapeutics' headquarters is located in North Haven, CT, US.

When was Insignis Therapeutics' last funding round?

Insignis Therapeutics' most recent funding round was for $500k (USD) in June 2023.

How much has Insignis Therapeutics raised to-date?

As of Jun 16, 2023, Insignis Therapeutics has raised a total of $500k (USD).

How many employees does Insignis Therapeutics have?

Insignis Therapeutics has 5 employees as of Feb 5, 2024.

Insignis Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research